Table 2.

In vivo echocardiograph of cTnI-ND,Tnni3−/− and WT mice and the effect of ISO treatment

WT (n = 5)cTnI-ND,Tnni3−/− (n = 5)
BaselineISO treatedΔ differenceBaselineISO treatedΔ difference
Body weight (g) 17.54 ± 0.36 17.07 ± 0.21 
Heart rate (bpm) 481.8 ± 3.75 518.4 ± 2.77 +36.6 ± 5.12 482.6 ± 4.35 514 ± 8.48 +31.4 ± 7.32 
LVEDD (mm) 2.89 ± 0.11 2.65 ± 0.07 −0.23 ± 0.06 3.04 ± 0.08 2.78 ± 0.10 −0.26 ± 0.06 
LVESD (mm) 1.44 ± 0.06 1.162 ± 0.06 −0.28 ± 0.08 1.58 ± 0.12 1.04 ± 0.12 −0.55 ± 0.03* 
Fractional shortening % 50.51 ± 1.24 57.55 ± 2.08 +7.04 ± 1.80 48.07 ± 2.88 62.87 ± 3.53 +14.8 ± 1.39* 
Ejection fraction % 83.09 ± 1.08 88.45 ± 1.51 +5.36 ± 1.50 80.24 ± 3.132 91.53 ± 2.22 +11.29 ± 1.29* 
WT (n = 5)cTnI-ND,Tnni3−/− (n = 5)
BaselineISO treatedΔ differenceBaselineISO treatedΔ difference
Body weight (g) 17.54 ± 0.36 17.07 ± 0.21 
Heart rate (bpm) 481.8 ± 3.75 518.4 ± 2.77 +36.6 ± 5.12 482.6 ± 4.35 514 ± 8.48 +31.4 ± 7.32 
LVEDD (mm) 2.89 ± 0.11 2.65 ± 0.07 −0.23 ± 0.06 3.04 ± 0.08 2.78 ± 0.10 −0.26 ± 0.06 
LVESD (mm) 1.44 ± 0.06 1.162 ± 0.06 −0.28 ± 0.08 1.58 ± 0.12 1.04 ± 0.12 −0.55 ± 0.03* 
Fractional shortening % 50.51 ± 1.24 57.55 ± 2.08 +7.04 ± 1.80 48.07 ± 2.88 62.87 ± 3.53 +14.8 ± 1.39* 
Ejection fraction % 83.09 ± 1.08 88.45 ± 1.51 +5.36 ± 1.50 80.24 ± 3.132 91.53 ± 2.22 +11.29 ± 1.29* 

In vivo cardiac functions were measured using echocardiography in 2-mo-old female WT and cTnI-ND,Tnni3−/− double transgenic mice. The ISO treatment (0.2 mg/kg) was given by i.p. injection. The functional parameters showed changes after ISO treatment as compared with the baseline in both WT and cTnI-ND,Tnni3−/− groups, in which paired Student’s t test showed significantly larger responses in LVESD, fraction shortening, and ejection fraction (*P < 0.05 vs. WT control). The values shown are mean ± SEM. n = 5 mice in each group.

or Create an Account

Close Modal
Close Modal